Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,207,601 papers from all fields of science
Search
Sign In
Create Free Account
Stage IV Pancreatic Cancer
Known as:
Stage IV Pancreatic Cancer AJCC v6
, Stage IV Carcinoma of the Pancreas
, Stage IV Pancreatic Cancer AJCC v7
Expand
Cancer may be of any size and has spread to distant organs, such as the liver, lung, and peritoneal cavity (the body cavity that contains most of the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Epithelial Cells
Epithelium
Exocrine pancreas
Gastrointestinal system
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Longitudinal Health-Related Quality of Life Assessment Implications for Prognosis in Stage IV Pancreatic Cancer
D. Braun
,
D. Gupta
,
E. Staren
Pancreas
2013
Corpus ID: 1953209
Objectives We investigated whether changes in quality of life (QoL) during treatment could predict survival in stage IV…
Expand
2012
2012
Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome.
B. Vizio
,
A. Novarino
,
+5 authors
G. Bellone
Experimental and Therapeutic Medicine
2012
Corpus ID: 33610558
CD4(+)CD25(+)FoxP3(+) regulatory T cells (Tregs) are understood to maintain peripheral tolerance to self-antigens and inhibit…
Expand
2009
2009
Metastatic Pancreatic Carcinoma Presenting as Colon Carcinoma
C. Bellows
,
T. Gage
,
M. Stark
,
Curt L McCarty
,
S. Haque
Southern medical journal (Birmingham, Ala. Print)
2009
Corpus ID: 24256451
Determining the origin of poorly differentiated adenocarcinomas remains a challenge for the pathologist. This manuscript reports…
Expand
2005
2005
A phase II study of erlotinib in combination with capecitabine in previously treated patients with metastatic pancreatic cancer
L. Blaszkowsky
,
K. Kulke
,
+5 authors
C. Fuchs
2005
Corpus ID: 74089302
4099 Background: Patients with advanced pancreatic cancer who fail first-line gemcitabine-based therapy have no standard…
Expand
2004
2004
Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group.
R. van Rijswijk
,
K. Jeziorski
,
+4 authors
J. Wils
European Journal of Cancer
2004
Corpus ID: 6773442
2004
2004
Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma
F. Meyer
,
A. Lueck
,
A. Hribaschek
,
H. Lippert
,
K. Ridwelski
Chemotherapy
2004
Corpus ID: 38266223
Background: In advanced pancreatic carcinoma, no effective chemotherapy has been found yet due to the lack of appropriate…
Expand
Highly Cited
2003
Highly Cited
2003
The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
Daniela Bruell
,
M. Stöcker
,
+9 authors
S. Barth
International Journal of Oncology
2003
Corpus ID: 24821206
Pancreatic carcinoma still has the highest mortality rate in comparison to any other malignancy. Major reasons are late detection…
Expand
Highly Cited
2003
Highly Cited
2003
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial.
V. Hess
,
M. Salzberg
,
+4 authors
R. Herrmann
Journal of Clinical Oncology
2003
Corpus ID: 26450824
PURPOSE Preclinical studies indicate positive interactions between capecitabine, an oral fluorouracil precursor, and gemcitabine…
Expand
2000
2000
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer…
S. Cascinu
,
L. Frontini
,
+9 authors
G. Catalano
Annals of Oncology
2000
Corpus ID: 27420183
BACKGROUND Laboratory evidences suggest the possibility that an infusion rate of 10 mg/m2/min may be more effective than the…
Expand
1998
1998
Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids.
F. Recchia
,
G. Sica
,
D. Casucci
,
S. Rea
,
A. Gulino
,
L. Frati
American Journal of Clinical Oncology
1998
Corpus ID: 25071491
Because of the poor response of pancreatic cancer to conventional therapy, the authors performed a phase II pilot study to…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE